What We Offer
We provide end-to-end support to bring innovative medical technologies into clinical practice across Japan and Asia - bridging global innovation with real-world healthcare needs.
Clinical Development & Regulatory Strategy
Overview
We support the clinical development and regulatory pathway of diagnostic technologies and medical devices, ensuring alignment with Japan and Asia’s complex healthcare systems.
Details
Our services include:
-
Clinical development strategy design tailored to local requirements
-
Study planning and coordination with leading academic institutions
-
Regulatory pathway assessment and approval strategy
-
Support for interactions with regulatory authorities
-
End-to-end project management from early validation to approval
Value
We enable efficient and credible clinical validation, accelerating time to market while maintaining the highest standards of scientific and regulatory rigor.
Market Entry & Localization
Overview
We help global healthcare companies successfully enter and expand in Japan and Asia by navigating regulatory, clinical, and market-specific complexities.
Details
Our services include:
-
Market entry strategy and positioning
-
Localization of products and clinical protocols
-
Stakeholder engagement (academic institutions, hospitals, KOLs)
-
Partnership development and ecosystem integration
-
Go-to-market planning and execution support
Value
We reduce uncertainty and shorten the path to successful market penetration in one of the world’s most complex healthcare regions.
Clinical Implementation & Scale-up
Overview
We drive the real-world adoption of medical technologies through structured clinical implementation and scalable deployment across institutions.
Details
Our services include:
-
Clinical feasibility studies (PoC) and early validation
-
Implementation planning with hospitals and clinical networks
-
Multi-site deployment across Japan and Asia
-
Data generation for further expansion and validation
-
Continuous support for post-launch optimization
Value
We ensure that validated technologies move beyond pilot phases and achieve meaningful clinical impact at scale.
Our
Track-record
Strong Achievements
Our leadership team has a proven track record of successfully bringing innovative medical technologies into the Japanese market - from clinical development to regulatory approval and real-world implementation
With deep experience in oncology and precision medicine, our team has led multiple successful market entries of international diagnostic technologies into Japan.
Key achievements include:
-
Regulatory approval of multi-gene diagnostic panels for lung cancer
-
Approval and clinical adoption of companion diagnostics for targeted therapies
-
End-to-end execution from clinical development and regulatory strategy to commercialization and clinical integration
.